Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 126, 2020 - Issue 3
251
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Can maternal treatment with metformin during gestation and lactation cause metabolic and cardiovascular disorders in rat offspring?

, , , , , , , ORCID Icon, & ORCID Icon show all
Pages 276-281 | Received 27 Jun 2018, Accepted 27 Aug 2018, Published online: 29 Sep 2018

References

  • Balani, J., et al., 2009. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study. Diabetic medicine, 26 (8), 798–802.
  • Battin, M.R., et al., 2015. Blood pressure measurement at two years in offspring of women randomized to a trial of metformin for GDM: follow up data from the MiG trial. BMC pediatrics, 15 (1), 54.
  • Bolton, S., et al., 2009. Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity. European journal of pediatrics, 168 (2), 203–206.
  • Campbell, I.W., et al., 1987. The effect of metformin on glycaemic control, intermediary metabolism and blood pressure in non-insulin-dependent diabetes mellitus. Diabetic medicine, 4 (4), 337–341.
  • Carlsen, S.M., Martinussen, M.P., and Vanky, E., 2012. Metformin's effect on first-year weight gain: a follow-up study. Pediatrics, 130 (5), e1222–e1226.
  • Carvalho-Filho, M.A., et al., 2005. S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes, 54 (4), 959–967.
  • Duncan, A.F., et al., 2011. Elevated systolic blood pressure in preterm very-low-birth-weight infants ≤3 years of life. Pediatric nephrology, 26 (7), 1115–1121.
  • Falholt, K., Lund, B., and Falholt, B., 1973. An Easy Colorimetric Micromethod for routine determination of free fatty acids in plasma. Clinica chimica acta; international journal of clinical chemistry, 46 (2), 105–111.
  • Forcato, S., et al., 2017. In utero and lactational exposure to metformin induces reproductive alterations in male rat offspring. Reproductive toxicology, 74, 48–58.
  • Gilbert, C., Valois, M., and Koren, G., 2006. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertility and sterility, 86 (3), 658–663.
  • Glatstein, M.M., et al., 2009. Use of hypoglycemic drugs during lactation. Canadian family physician, 55 (4), 371–373.
  • Gluckman, P.D., et al., 2009. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nature reviews. Endocrinology, 5 (7), 401–408.
  • Glueck, C.J., et al., 2008. POLYCYSTIC OVARY SYNDROME Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertility and sterility, 89 (3), 625–634.
  • Glueck, C.J., et al., 2002. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Human reproduction (Oxford, England), 17 (11), 2858–2864.
  • Gutzin, S.J., et al., 2003. The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis. The Canadian journal of clinical pharmacology = journal Canadien de pharmacologie clinique, 10 (4), 179–183.
  • Harris, K., et al., 2016. The effects of prenatal metformin on obesogenic diet-induced alterations in maternal and fetal fatty acid metabolism. Nutrition & metabolism, 13 (1), 55.
  • Hawley, S.A., et al., 2002. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes, 51 (8), 2420–2425.
  • Holmes, B.F., Kurth-Kraczek, E.J., and Winder, W.W., 1999. Chronic activation of 5’-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. Journal of applied physiology (Bethesda, Md.: 1985), 87 (5), 1990–1995.
  • Hundal, H.S., et al., 1992. Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology, 131 (3), 1165–1173.
  • Johnson, N., 2011. Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome-a meta-analysis of randomised trials . The Australian &Amp; New Zealand journal of obstetrics and gynaecology, 51 (2), 125–129.
  • Knowler, W.C., Diabetes Prevention Program Research Group., et al., 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England journal of medicine, 346 (6), 393–403.
  • Kovo, M., et al., 2008. Determination of metformin transfer across the human placenta using a dually perfused ex vivo placental cotyledon model. European journal of obstetrics gynecology and reproductive biology, 136 (1), 29–33.
  • Lobato, N.S., et al., 2012. Improvement of metabolic parameters and vascular function by metformin in obese non-diabetic rats. Life sciences, 90 (5–6), 228–235.
  • Long, Y.C. and Zierath, J.R., 2006. AMP-activated protein kinase signaling in metabolic regulation. The journal of clinical investigation, 116 (7), 1776–1783.
  • Morin-Papunen, L., et al., 2012. Metformin improves pregnancy and live-birth rates in women with Polycystic Ovary Syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. The journal of clinical endocrinology and metabolism, 97 (5), 1492–1500.
  • Novi, D.R.B.S., et al., 2017. Metformin exposure during pregnancy and lactation did not cause vascular reactivity alteration in adult male offspring. Journal of cardiovascular pharmacology, 1, 300–304.
  • Petersen, J.S. and DiBona, G.F., 1996. Acute sympathoinhibitory actions of metformin in spontaneously hypertensive rats. Hypertension, 27 (3), 619–625.
  • Ribeiro Filho, F.F., et al., 2006. Gordura visceral e síndrome metabólica: mais que uma simples associação. Arquivos brasileiros de endocrinologia and metabologia, 50 (2), 230–238.
  • Rø, T.B., et al., 2012. Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero. Scandinavian journal of clinical and laboratory investigation, 72 (7), 570–575.
  • Rowan, J.A., et al., 2011. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes care, 34 (10), 2279–2284.
  • Salomäki, H., et al., 2013. Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood. PLoS One, 8 (2), e56594–e56512.
  • Scheepers, H.C.J., et al., 2001. Fetal and maternal energy metabolism during labor in relation to the available caloric substrate. Journal of perinatal medicine, 29 (6), 457–464.
  • Sinclair, K.D., et al., 2007. The developmental origins of health and disease: current theories and epigenetic mechanisms. Reproduction in domestic ruminants, 6 (1), 425–443.
  • Steinberg, G.R. and Kemp, B.E., 2009. AMPK in health and disease. Physiological reviews, 89 (3), 1025–1078.
  • Stumvoll, M., et al., 1995. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. New England journal of medicine, 333 (9), 550–554.
  • Vidigal, C., et al., 2018. Intrauterine exposure to metformin: evaluation of endothelial and perivascular adipose tissue function in abdominal aorta of adult offspring. Life sciences, 207, 72–79.
  • Viollet, B., et al., 2012. Cellular and molecular mechanisms of metformin: an overview. Clinical science, 122 (6), 253–270.
  • Wong, R., et al., 2012. Building hospital management capacity to improve patient flow for cardiac catheterization at a cardiovascular hospital in Egypt. Joint commission journal on quality and patient safety, 38 (4), 147–153.
  • Wulffelé, M.G., et al., 2005. Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin? Diabetic medicine, 22 (7), 907–913.
  • Zhou, G., et al., 2001. Role of AMP-activated protein kinase in mechanism of metformin action. The journal of clinical investigation, 108 (8), 1167–1174.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.